The interferon consensus sequence binding protein (Icsbp/ Irf8) is required for termination of emergency granulopoiesis

Journal of Biological Chemistry

Volumn 291, Issue 8, 2016, Pages 4107-4120

  Hu, Liping ^a   Huang, Weiqi ^a,b   Hjort, Elizabeth E ^a   Bei, Ling ^a,b   Platanias, Leonidas C ^a,b   Eklund, Elizabeth A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BINS; BONE; CELL DEATH; DISEASES; ENCODING (SYMBOLS); GENE EXPRESSION; GENES; GLYCOPROTEINS; IMMUNE SYSTEM; MAMMALS; PROTEINS; TRANSCRIPTION;

ACUTE MYELOID LEUKEMIA; CHRONIC MYELOID LEUKEMIAS; INDUCED APOPTOSIS; INNATE IMMUNE RESPONSE; INTERFERON CONSENSUS SEQUENCE-BINDING PROTEINS; LEUKEMOGENESIS; MOLECULAR EVENTS; PROGENITOR CELL;

EMERGENCY SERVICES;

BETA CATENIN; DNA; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY TRANSCRIPTION FACTOR; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; FAS ANTIGEN; FAS PROTEIN, MOUSE; GAS2 PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA DAMAGE; EMERGENCY GRANULOPOIESIS; GENETIC CODE; GRANULOCYTOSIS; GRANULOPOIESIS; INNATE IMMUNITY; LEUKEMOGENESIS; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; APOPTOSIS; CYTOLOGY; GENETICS; GRANULOCYTE; HUMAN; KNOCKOUT MOUSE; LEUKOPOIESIS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BETA CATENIN; GRANULOCYTES; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; LEUKOPOIESIS; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13;

EID: 84964495035     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.681361     Document Type: Article

References (47)

1. Lieschke, G. J., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K. J., Basu, S., Zhan, Y. F., and Dunn, A. R. (1994) Mice lacking G-CSF have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency and impaired neutrophil mobilization. Blood 84, 1737-1746.
2. Panopoulos, A. D., and Watowich, S. S. (2008) Granulocyte colony stimulating factor: molecular mechanisms of activation during steady state and emergency hematopoiesis. Cytokine 42, 277-288.
3. DeKoter, R. P., Walsh, J. C., and Singh, H. (1998) PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17, 4456-4468.
4. Zhang, D. E., Zhang, P., Wang, N. D., Hetherington, C. J., Darlington, G. J., and Tenen, D. G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94, 569-574.
5. Ueda, Y., Cain, D. W., Kuraoka, M., Kondo, M., and Kelsoe, G. (2009) IL1R type I dependent hematopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 182, 6477-6484.
6. Cain, D. W., Snowden, P. B., Sempowski, G. D., and Kelsoe, G. (2011) Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS ONE 6, e19957.
7. Hirai, H., Zhang, P., Dayaram, T., Hetherington, C. J., Mizuno, S., Imanishi, J., Akashi, K., and Tenen, D. G. (2006) C/EBPβ is required for "emergency" granulopoiesis. Nat. Immunol. 7, 732-739.
8. Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J., and Watowich, S. S. (2006) Stat3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108, 3682-3690.
9. Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R., and Cheers, C. (1998) Essential roles for GM-CSF and G-CSF in the sustained hematopoietic response of Listeria monocytogenes infected mice. Blood 91, 863-869.
10. Basu, S., Hodgson, G., Zhang, H. H., Katz, M., Quilici, C., and Dunn, A. R. (2000) Emergency granulopoiesis in G-CSF deficient mice in response to Candida albicans infection. Blood 95, 3725-3733.
11. Eash, K. J., Means, J. M., White, D. W., and Link, D. C. (2009) CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113, 4711-4719.
12. Hu, L., Huang, W., Hjort, E., and Eklund, E. A. (2013) Increased Fanconi C expression contributes to the emergency granulopoiesis response. J. Clin. Invest. 123, 3952-3966.
13. Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., and Ozato, K. (1990) An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U.S.A. 87, 3743-3747.
14. Scheller, M., Foerster, J., Heyworth, C. M., Waring, J. F., Löhler, J., Gilmore, G. L., Shadduck, R. K., Dexter, T. M., and Horak, I. (1999) Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 94, 3764-3771.
15. Eklund, E. A., Jalava, A., and Kakar, R. (1998) PU.1, interferon regulatory factor 1, and interferon consensus sequence binding protein cooperate to increase gp91phox expression. J. Biol. Chem. 273, 13957-13965.
16. Eklund, E. A., and Kakar, R. (1999) Recruitment of CBP by PU.1, IRF1 and ICSBP is necessary for gp91phox and p67phox expression. J. Immunol. 163, 6095-6105.
17. Konieczna, I., Horvath, E., Wang, H., Lindsey, S., Saberwal, G., Bei, L., Huang, W., Platanias, L., and Eklund, E. A. (2008) Constitutive activation of SHP2 cooperates with ICSBP-deficiency to accelerate progression to acute myeloid leukemia. J. Clin. Invest. 118, 853-867.
18. Huang, W., Saberwal, G., Horvath, E., Zhu, C., Lindsey, S., and Eklund, E. A. (2006) Leukemia associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1-transcriptional activation by the interferon consensus sequence binding protein. Mol. Cell Biol. 26, 6311-6332.
19. Kakar, R., Kautz, B., and Eklund, E. A. (2005) JAK2 is necessary and sufficient for interferon -induced transcription of the gene encoding gp91PHOX. J. Leukocyte Biol. 77, 120-127.
20. Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., Friend, S., and Linsley, P. S. (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 103, 2794-2799.
21. Huang, W., Zhu, C., Wang, H., Horvath, E., and Eklund, E. A. (2008) The interferon consensus sequence binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells. J. Biol. Chem. 283, 7921-7935.
22. Huang W., Zhou W., Saberwal G., Konieczna I., Horvath E., Katsoulidis E., Platanias L. C., and Eklund E. A. (2010) The interferon consensus sequence binding protein (ICSBP) decreases Bcatenin-activity in myeloid cells by repressing GAS2 transcription. Mol. Cell Biol. 30, 4575-4594.
23. Huang W., Bei L., and Eklund E. A. (2013) Fas-associated phosphatase 1 (Fap1) mediates Fas-resistance in myeloid progenitor cells expressing the Bcr-abl oncogene. Leuk. Lymphoma 54, 619-630.
24. Hao, S. X., and Ren, R. (2000) Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol. Cell. Biol. 20, 1149-1161.
25. Burchert, A., Cai, D., Hofbauer, L. C., Samuelsson, M. K., Slater, E. P., Duyster, J., Ritter, M., Hochhaus, A., Müller, R., Eilers, M., Schmidt, M., and Neubauer, A. (2004) Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103, 3480-3489.
26. Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zinkernagel, R. M., Morse, H. C. 3rd, Ozato, K., and Horak, I. (1996) Immuno-deficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317.
27. Rehli, M., Poltorak, A., Schwarzfischer, L., Krause, S. W., Andreesen, R., and Beutler, B. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-9781.
28. Kurotaki, D., Osato, N., Nishiyama, A., Yamamoto, M., Ban, T., Sato, H., Nakabayashi, J., Umehara, M., Miyake, N., Matsumoto, N., Nakazawa, M., Ozato, K., and Tamura, T. (2013) Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 121, 1839-1849.
29. Saberwal, G., Horvath, E., Hu, L., Zhu, C., Hjort, E., and Eklund, E. A. (2009) The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation. J. Biol. Chem. 284, 33242-33254.
30. Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., and Ozato, K. (2000) ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13, 155-165.
31. Kurotaki, D., Yamamoto, M., Nishiyama, A., Uno, K., Ban, T., Ichino, M., Sasaki, H., Matsunaga, S., Yoshinari, M., Ryo, A., Nakazawa, M., Ozato, K., and Tamura, T. (2014) IRF8 inhibits C/EBPa activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils. Nat. Commun. 19, 4978.
32. Iwama, A., Osawa, M., Hirasawa, R., Uchiyama, N., Kaneko, S., Onodera, M., Shibuya, K., Shibuya, A., Vinson, C., Tenen, D. G., and Nakauchi, H. (2002) Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription actors in Langerhans cell commitment. J. Exp. Med. 195, 547-558.
33. Benetti, R., Copetti, T., Dell'Orso, S., Melloni, E., Brancolini, C., Monte, M., and Schneider, C. (2005) The calpain system is involved in the constitutive regulation of β-catenin signaling functions. J. Biol. Chem. 280, 22070-22080.
34. Yanagisawa, J., Takahashi, M., Kanki, H., Yano-Yanagisawa, H., Tazunoki, T., Sawa, E., Nishitoba, T., Kamishohara, M., Kobayashi, E., Kataoka, S., and Sato, T. (1997) The molecular interaction of Fas and FAP-1: A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272, 8539-8545.
35. Huang, W., Bei, L., and Eklund, E. A. (2013) Fas associated phosphatase 1 (Fap1) influences -catenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene. J. Biol. Chem . 288, 12766-12776.
36. Zheng, C., Li, L., Haak, M., Brors, B., Frank, O., Giehl, M., Fabarius, A., Schatz, M., Weisser, A., Lorentz, C., Gretz, N., Hehlmann, R., Hochhaus, A., and Seifarth, W. (2006) Gene expression profiling of CD34〈 cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia 20, 1028-1034.
37. Ward, A. C., van Aesch, Y. M., Schelen, A. M., and Touw, I. P. (1999) Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood. 93, 447-458.
38. Kool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., and Tschopp, J. (2008) Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181, 3755-3759.
39. Kim, Y. M., Kang, H. S., Paik, S. G., Pyun, K. H., Anderson, K. L., Torbett, B. E., and Choi, I. (1999) Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J. Immunol. 163, 2000 -2007.
40. Stoffel, R., Wiestner, A., and Skoda, R. C. (1996) Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role for platelets. Blood 87, 567-573.
41. Salto, Y., Boddupalli, C. S., Borsotti, C, and Manz, M. C. (2013) Dendritic cell homeostasis is maintained by non-hematopoietic and T-cell produced Flt3-ligand in steady state and during the immune responses. Eur. J. Immunol. 43, 1651-1658.
42. Huang, W., Hu, L., Bei, L., Hjort, E., and Eklund, E. A. (2012) The leukemia- Associated fusion-protein Tel-platelet derived growth factor receptor B (Tel-PdgfRB) inhibits transcriptional repression of the PTPN13 gene by the interferon consensus sequence binding protein (Icsbp). J. Biol. Chem. 287, 8110-8125.
43. Lord, B. I., Molineux, G., Pojda, Z., Souza, L. M., Mermod, J.-J., and Dexter, T. M. (1991) Myeloid cell kinetics in mice treated with recombinant interleukin- 3, granulocyte colony-stimulating factor (CSF), or granulocytemacrophage CSF in vivo. Blood 77, 2154-2159.
44. Kreisel, D., Sugimoto, S., Zhu, J., Nava, R., Li, W., Okazaki, M., Yamamoto, S., Ibrahim, M., Huang, H. J., Toth, K. A., Ritter, J. H., Krupnick, A. S., Miller, M. J., and Gelman, A. E. (2011) Emergency granulopoiesis promoter neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood 118, 6172-6182.
45. Schlacher, K., Wu, H., and Jasin, M. (2012) A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to Rad51-BrCA1/2. Cancer Cell 22, 106-116.
46. Wang, L.C., Stone, S., Hoatlin, M.E., and Gautier, J. (2008) Fanconi anemia proteins stabilize replication forks. DNA Repair 7, 1973-1981.
47. Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., and D'Andrea, A. D. (2002) S-phase specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100, 2414-2420.